Annual report
4350.TEDINET S100R0WL
Period2022-04-01 → 2023-03-31
Filed2023-06-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥109.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥106.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥104.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥105.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.9bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥895m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥462m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥66.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥62.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥64.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥66.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥68.9bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥51.7bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥49.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥11.2bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥9.4bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥10.8bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥53.38 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.35 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.51 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-29.48 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.25 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.04 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥478.86 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥439.67 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥370.23 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥310.39 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥354.77 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 21.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.2% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 21.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,619 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,514 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 3,326 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,205 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 3,076 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥8.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥7.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥6.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥429m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥404m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥902m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.1bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.2bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥2.2bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥53.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥53.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥54.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥57.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥57.0bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥37.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥14.6bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥71.75 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.89 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.01 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.74 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.82 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥47.64 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.65 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥12 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥606.46 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥547.69 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥483.95 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥450.36 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥416.39 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 34.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 30,642,600 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,642,600 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 354 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 337 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 285 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 262 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 257 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Otherother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥1m |
| Otherother segments | employees | at 2023-03-31 | 38 pure |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥304m |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥304m |
| Otherother segments | segment assets | at 2023-03-31 | ¥63m |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥22m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥247m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥128m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥937m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥937m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥2.5bn |
| Community Pharmacy Network Segmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥4.6bn |
| Community Pharmacy Network Segmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Community Pharmacy Network Segmentreportable segment | employees | at 2023-03-31 | 3145 pure |
| Community Pharmacy Network Segmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥104.4bn |
| Community Pharmacy Network Segmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥104.4bn |
| Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥32m |
| Community Pharmacy Network Segmentreportable segment | segment assets | at 2023-03-31 | ¥46.1bn |
| Community Pharmacy Network Segmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥5.9bn |
| Lunch Catering Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8m |
| Lunch Catering Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1m |
| Lunch Catering Businessreportable segment | employees | at 2023-03-31 | 168 pure |
| Lunch Catering Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| Lunch Catering Businessreportable segment | segment assets | at 2023-03-31 | ¥720m |
| Lunch Catering Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥65m |
| Rental Facility Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥114m |
| Rental Facility Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥575m |
| Rental Facility Relatedreportable segment | employees | at 2023-03-31 | 134 pure |
| Rental Facility Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Rental Facility Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.6bn |
| Rental Facility Relatedreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥903m |
| Rental Facility Relatedreportable segment | segment assets | at 2023-03-31 | ¥16.8bn |
| Rental Facility Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥92m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥110.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥109.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥937m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥63.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| Otherother segments | capex | 2021-04-01 → 2022-03-31 | ¥3m |
| Otherother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥0 |
| Otherother segments | revenue | 2021-04-01 → 2022-03-31 | ¥305m |
| Otherother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥305m |
| Otherother segments | segment assets | at 2022-03-31 | ¥62m |
| Otherother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥12m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥205m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥133m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥727m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥727m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥2.3bn |
| Community Pharmacy Network Segmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| Community Pharmacy Network Segmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥994m |
| Community Pharmacy Network Segmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥101.5bn |
| Community Pharmacy Network Segmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥101.5bn |
| Community Pharmacy Network Segmentreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥0 |
| Community Pharmacy Network Segmentreportable segment | segment assets | at 2022-03-31 | ¥43.0bn |
| Community Pharmacy Network Segmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥6.1bn |
| Lunch Catering Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥0 |
| Lunch Catering Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Lunch Catering Businessreportable segment | segment assets | at 2022-03-31 | ¥699m |
| Lunch Catering Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1m |
| Rental Facility Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥181m |
| Rental Facility Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥598m |
| Rental Facility Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.3bn |
| Rental Facility Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.6bn |
| Rental Facility Relatedreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥726m |
| Rental Facility Relatedreportable segment | segment assets | at 2022-03-31 | ¥17.5bn |
| Rental Facility Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥39m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥107.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥106.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥727m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥61.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥6.1bn |
| Otherother segments | employees | at 2023-03-31 | 38 pure |
| Community Pharmacy Network Segmentreportable segment | employees | at 2023-03-31 | 67 pure |
| Rental Facility Relatedreportable segment | employees | at 2023-03-31 | 115 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,584
| Item | Context | Value | Unit |
|---|---|---|---|
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 4000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_DeferredGainsOrLossesOnHedgesMember | 1000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 5000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember | 1773000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_TreasuryStockMember | -326000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember | 18298000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 1000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_DeferredGainsOrLossesOnHedgesMember | 2000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 3000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 18301000000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 1649000000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 1771000000 | JPY |
| Provision for bonuses sga | Prior1YearDuration_NonConsolidatedMember | 180000000 | JPY |
| Provision for bonuses sga | CurrentYearDuration_NonConsolidatedMember | 179000000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration_NonConsolidatedMember | 38000000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration_NonConsolidatedMember | 2000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 92000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 89000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | Prior1YearDuration_NonConsolidatedMember | 32000000 | JPY |
| Provision for share based remuneration for directors and other officers sga | CurrentYearDuration_NonConsolidatedMember | 32000000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 181000000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 181000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)北海道財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-22 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第25期(自 2022年４月１日 至 2023年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディカルシステムネットワーク | |
| Company name in english cover page | FilingDateInstant | MEDICAL SYSTEM NETWORK Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 田 尻 稲 雄 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)札幌市中央区北十条西二十四丁目３番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)011(612)1069(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役常務執行役員経理財務本部長 平 島 英 治 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)札幌市中央区北十条西二十四丁目３番地 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)011(612)1069(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役常務執行役員経理財務本部長 平 島 英 治 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05274 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 43500 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディカルシステムネットワーク | |
| Filer name in english | FilingDateInstant | MEDICAL SYSTEM NETWORK Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |